Helping patients and doctors make better decisions about lung cancer screening
Engaging patients to enable interoperable lung cancer decision support at scale
This study is all about helping people who have smoked a lot to get important lung cancer screenings by using a special tool that helps doctors find out who might need it and gives them helpful information to make the best choices together.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10890591 on NIH RePORTER |
What this research studies
This research focuses on improving lung cancer screening rates among eligible patients, particularly those with a history of heavy smoking. It utilizes a tool called Decision Precision+ that analyzes electronic health records to identify patients who may benefit from low-dose computed tomography (LDCT) screening. By providing tailored information about the benefits and risks of screening, the tool aids doctors and patients in making informed decisions. The goal is to increase the number of patients receiving potentially life-saving lung cancer screenings.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of heavy smoking who are eligible for lung cancer screening.
Not a fit: Patients who do not have a history of heavy smoking or who are not eligible for lung cancer screening may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase early detection of lung cancer, leading to better patient outcomes and reduced mortality rates.
How similar studies have performed: Previous implementations of similar decision support tools have shown success in increasing screening rates and improving patient outcomes.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Kawamoto, Kensaku — University of Utah
- Study coordinator: Kawamoto, Kensaku
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.